1-2 of 2
Timothy Voorhees
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Siltuximab for chimeric antigen receptor T-cell therapy–related CRS and ICANS: a multicenter retrospective analysis

Amneet Bajwa, Qiuhong Zhao, Marcus Geer, Chenyu Lin, James Westholder, Joseph Maakaron, Monalisa Ghosh, David Frame, Ahmed Galal, Justin Tossey, Nausheen Ahmed, Evandro Bezerra, Nathan Denlinger, Marcos de Lima, Narendranath Epperla, Paolo Caimi, Timothy Voorhees
Journal: Blood Advances
Blood Adv (2025) 9 (1): 170–175.
https://doi.org/10.1182/bloodadvances.2024013688
Published: 2025
Journal Articles

Successful obinutuzumab administration after rituximab discontinuation due to intolerance in patients with hematologic disorders

Clinical Trials & Observations
Timothy Schieber, Anthony Li, Jordan Lundberg, Tracy Wiczer, Timothy Voorhees
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3431–3434.
https://doi.org/10.1182/bloodadvances.2022009548
Published: 2023